Other psychoactive substance dependence, uncomplicated
ICD-10 F19.20 is a billable code used to indicate a diagnosis of other psychoactive substance dependence, uncomplicated.
F19.20 refers to a diagnosis of dependence on psychoactive substances that are not classified under other specific categories. This includes substances such as inhalants, synthetic cannabinoids, and other non-specified drugs that lead to a pattern of compulsive use despite harmful consequences. Patients may exhibit tolerance, withdrawal symptoms, and a strong desire to consume the substance. Unlike complicated cases, this code indicates that the individual does not have associated medical or psychiatric complications. Treatment often involves behavioral therapies, counseling, and support groups, focusing on reducing substance use and preventing relapse. The diagnosis requires thorough documentation of the patient's substance use history, including frequency, quantity, and impact on daily functioning. Clinicians must also assess for any co-occurring mental health disorders, which can complicate treatment and recovery.
Detailed substance use history, treatment plans, and progress notes.
Patients seeking help for substance use, undergoing detoxification, or in outpatient treatment.
Ensure clear documentation of the absence of complications and any co-occurring disorders.
Comprehensive mental health evaluations, including assessments for co-occurring disorders.
Patients presenting with mood disorders alongside substance dependence.
Document any psychiatric evaluations and treatment plans that address both substance use and mental health.
Used in conjunction with F19.20 for patients seeking help with tobacco dependence.
Document the counseling session details and patient progress.
Ensure that the counseling aligns with the substance dependence diagnosis.
F19.20 is used for uncomplicated psychoactive substance dependence, while F19.21 is for cases where withdrawal symptoms are present, indicating a more complex condition.
